logo
Select company
Select metric
$ -9.39MEarning Before Interest & Taxes (EBIT)
VS
Market
31
Sector
65
Industry
80
History
93
$ 0.68Close
$ 0.58 - $ 3.8 52-Week Range
Ticker Information

Ticker

GTBP

Company Name

GT BIOPHARMA INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

GT BIOPHARMA INC - Earning Before Interest & Taxes (EBIT) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

GTBP - EBIT Historical data
DateEarning Before Interest & Taxes (EBIT)
6/30/2025$ -9.39M
3/31/2025$ -11.67M
12/31/2024$ -13.16M
9/30/2024$ -12.35M
6/30/2024$ -11.35M
3/31/2024$ -9.63M
12/31/2023$ -7.38M
9/30/2023$ -10M
6/30/2023$ -14.46M
3/31/2023$ -15.45M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • GT BIOPHARMA INC's latest trailing twelve months (TTM) EBIT stands at $ -7.97M.
  • Over the past 5 years, GT BIOPHARMA INC's average EBIT has been $ -24.49M.
  • The median EBIT for GT BIOPHARMA INC during this period was $ -14.96M
  • GT BIOPHARMA INC reached its highest EBIT over the past 5 years at $ -7.38M.
  • The lowest EBIT recorded by GT BIOPHARMA INC in the same timeframe $ -57.45M

Definition of Earning Before Interest & Taxes (EBIT)

[Income Statement] Earnings before interest and taxes measures a company's net income [NetInc] prior to the deduction of interest [IntExp] and tax expenses [TaxExp].

GTBP - Earning Before Interest & Taxes (EBIT), Last 5 years

$ -57.45M

Minimum

Sep 30, 2021

$ -7.38M

Maximum

Dec 31, 2023

$ -24.49M

Average

$ -14.96M

Median

EBIT Benchmark Analysis

The chart above depicts the distribution of EBIT for companies in the Total Stock Market. The average EBIT of the companies is $ 28.81M with a standard deviation of $ 130.86M.
The following table provides additional summary stats:
EBIT in the Market:
filtered constituents3.29K
min$ -402.08M
max$ 443M
average$ 28.81M
median$ 1.05M
std$ 130.86M